0 Commentarios
0 Acciones
1000 Views
0 Vista previa
Buscar
Descubre nuevas personas, crear nuevas conexiones y hacer nuevos amigos
- Please log in to like, share and comment!
- "Asthma Segment Dominates the COPD and Asthma Devices Market"The Infinium Global Research analyzes the Asthma and COPD Devices Market over the period of 2022 to 2028. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in global asthma and copd devices market. It will help a lot of decision makers to develop strategies and find new opportunities in the global markets of asthma and...0 Commentarios 0 Acciones 54 Views 0 Vista previa
- Asthma And COPD Drugs Market Analysis, Size, Share, and Forecast 2031The Asthma And COPD Drugs Market in 2023 is US$ 38.04 billion, and is expected to reach US$ 55.6 billion by 2031 at a CAGR of 4.90%. FutureWise Research published a report that analyzes Asthma And COPD Drugs Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the...0 Commentarios 0 Acciones 308 Views 0 Vista previa
- Asthma and COPD Drugs Market Projected to Grow at a Steady Pace During 2022-2028The Asthma and COPD Drugs Market is segmented by Drug Class Type (Combination Drugs, Bronchodilators, Inhaled Corticosteroids (ICS), Short Acting Beta Agonists (SABA), Long Acting Beta Agonists (LABA), Leukotriene Antagonists (LTA), Anticholinergics, Anti-Inflammatories, Others), by Application Type (Asthma and COPD), by Distribution Channel...0 Commentarios 0 Acciones 1333 Views 0 Vista previa
- Asthma And COPD Market Is Estimated To Witness High Growth Owing To Rising Incidence Of Asthma And COPD CasesAsthma and COPD are chronic lung diseases that cause obstruction of airflow in the lungs. Asthma is caused due to inflammation and narrowing of the airways leading to wheezing, chest tightness, shortness of breath etc. COPD mainly includes chronic bronchitis and emphysema causing damage to the lungs over a period of time due to exposure to noxious particles or gases. Products available in the...0 Commentarios 0 Acciones 815 Views 0 Vista previa
- Chronic Obstructive Pulmonary Disease (COPD) devicesMarket Trends, Revenue, Major Players, Share Analysis & Forecast Till 2032The Chronic Obstructive Pulmonary Disease (COPD) devices market is expected to see a steady increase in revenue from USD 8.3 billion in 2022 to USD 14.02 billion in 2032, with a Compound Annual Growth Rate (CAGR) of 6%. This growth is driven by several factors, including the increasing prevalence of COPD globally, a growing number of elderly people, and a rising demand for non-invasive devices....0 Commentarios 0 Acciones 1590 Views 0 Vista previa
- Chronic Obstructive Pulmonary Disease (COPD) Treatment market 2021 Comprehensive Research Methodology, Key Insights, Segments and Extensive Profiles by 2027Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Overview: Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. Tobacco smoking is the most common cause of COPD, with factors such as air pollution and genetics. There are several lifestyle-related factors such as smoking, exposure to...0 Commentarios 0 Acciones 2983 Views 0 Vista previa
- Chronic Obstructive Pulmonary Disease (COPD) Treatment Market is driven by increasing prevalence of COPDThe chronic obstructive pulmonary disease (COPD) treatment market encompasses a broad range of therapeutics including bronchodilators, corticosteroids, and combination therapies used for alleviating symptoms and slowing progression of COPD. Some of the commonly prescribed medications include inhaled corticosteroids, short-acting beta-2 agonists, long-acting beta-2 agonists, anticholinergics,...0 Commentarios 0 Acciones 552 Views 0 Vista previa
- Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Poised for Significant Growth due to Rising Prevalence of COPD GloballyChronic Obstructive Pulmonary Disease or COPD refers to a group of lung diseases that cause airflow blockage and breathing-related problems. It includes emphysema and chronic bronchitis. COPD treatments are aimed at slowing the progression of the disease and relieving symptoms. They include bronchodilators, corticosteroids, oxygen therapy, pulmonary rehabilitation, antibiotics and vaccines....0 Commentarios 0 Acciones 784 Views 0 Vista previa
- COPD and Asthma Devices Market Size, Analysis and Forecast 2031The COPD and Asthma Devices Market in 2023 is US$ 43.24 billion, and is expected to reach US$ 61.58 billion by 2031 at a CAGR of 4.5%. FutureWise Research published a report that analyzes COPD and Asthma Devices Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the...0 Commentarios 0 Acciones 106 Views 0 Vista previa
- Pulmonary Drugs: Effective Medications for Treating Respiratory ConditionsThe lungs are one of the most important organs in our body, responsible for delivering oxygen to our organs and removing carbon dioxide. Various pulmonary or respiratory conditions can affect the normal functioning of the lungs. Pulmonary drugs help in treating many such lung diseases and improving the respiratory health. BronchodilatorsBronchodilators are one of the most widely used classes...0 Commentarios 0 Acciones 908 Views 0 Vista previa
- Advances in Chronic Obstructive Pulmonary Disease TreatmentCOPD is a progressive lung disease that makes it hard to breathe. Over time, COPD gets worse and the lungs lose their ability to fully inflate and deflate properly. This damages the lungs and weakens the muscles that help with breathing. As COPD gets more severe, even minimal physical activity can become very tiring. There is no cure for COPD, but treatment can help manage symptoms, slow its...0 Commentarios 0 Acciones 680 Views 0 Vista previa
Resultados de la búsqueda